Senior insider sale
Chief Executive Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$1.68M
53.64K shares
What this filing means
BARROW ROBERT plans to sell 53.64K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $1.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/25/2026ACC: 0001950047-26-006487
DirectorOfficer· Chief Executive Officer
Since Jan 2022
53.64K
Shares to sell
$1.68M
Approx. market value
29.21K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
6/25/2026
29.21KTotal acquired29.21K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 29.21K | — |
| Total | 29.21K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
24.43K
Market value
$451.2K
3/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
29.21K
Market value
$1.23M
6/25/2026
Total
Units
53.64K
Value
$1.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/25/2026 | 24.43K | $451.2K | — | Completed |
| Planned — Approximate Date | ||||
6/25/2026 | 29.21K | $1.23M | NASDAQ | Planned |
| Total | 53.64K | $1.68M | ||